For decades, proponents of psychedelic drugs have pushed a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for patients grappling with depression, trauma and other hard-to-treat conditions.
In the United States, a presidential administration finally seems to agree.
